|
NARS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.01427763357742E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
4.805000E-01 |
| Stage1-vs-Stage3 |
1.786220E-01 |
| Stage1-vs-Stage4 |
9.222800E-01 |
| Stage2-vs-Stage3 |
1.346610E-01 |
| Stage2-vs-Stage4 |
5.909200E-01 |
| Stage3-vs-Stage4 |
2.966400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6242562850266E-12 |
| Normal-vs-AfricanAmerican |
1.62447832963153E-12 |
| Normal-vs-Asian |
6.20539997164826E-09 |
| Caucasian-vs-AfricanAmerican |
4.157400E-01 |
| Caucasian-vs-Asian |
4.610800E-01 |
| AfricanAmerican-vs-Asian |
3.309600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
8.592500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64201985342061E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.42620359966372E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.323200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.117400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.018800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.384800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.447000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.237600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.31950000317838E-08 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62436730732907E-12 |
| Grade 1-vs-Grade 2 |
7.770800E-01 |
| Grade 1-vs-Grade 3 |
3.903600E-01 |
| Grade 1-vs-Grade 4 |
2.416800E-01 |
| Grade 2-vs-Grade 3 |
1.888220E-01 |
| Grade 2-vs-Grade 4 |
8.284200E-02 |
| Grade 3-vs-Grade 4 |
4.748600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
3.610400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
5.423000E-03 |
| N0-vs-N1 |
2.040800E-01 |
|
|
